Hemispherx Biopharma Inc (HEB)-Financial and Strategic SWOT Analysis Review

Hemispherx Biopharma Inc (HEB)-Financial and Strategic SWOT Analysis Review


  • Products Id :- GDPH57136FSA
  • |
  • Pages: 44
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Hemispherx Biopharma Inc (HEB)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description-A detailed description of the company operations and business divisions.

Corporate strategy-Analyst summarization of the company business strategy.

SWOT Analysis-A detailed analysis of the company strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Hemispherx Biopharma Inc (Hemispherx) is a biopharmaceutical company, which develops, manufactures and commercializes drug therapies for the treatments of viral and immune based chronic disorders. It offers products for the treatment of various diseases such as hepatitis B, hepatitis C, chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME), kidney cancer and metastatic malignant melanoma; multiple sclerosis, hepatitis C, HIV, west Nile virus, and SARS; and Alferon LDO (Low Dose Oral), an oral form of Alferon N Injection for influenza viruses. The company operates production facility in New Brunswick, New Jersey, which is designed to produce Alferon and Ampligen. Hemispherx is headquartered in Pennsylvania, the US.

Hemispherx Biopharma Inc Key Recent Developments

Mar 31,2017: Hemispherx Biopharma Announces Financial Results for the Year Ended December 31, 2016

Nov 14,2016: Hemispherx Biopharma Announces Financial Results in its Quarterly Report for the Nine Months Ended September 30, 2016

Sep 22,2016: Hemispherx Biopharma Announces Granting of Final Settlement of Derivative and Class Action Case

Aug 19,2016: Hemispherx Biopharma Forms Scientific Advisory Board to Provide Additional Scientific and Pharmaceutical Expertise

Aug 15,2016: Hemispherx Biopharma Announces Financial Results for the Six Months Ended June 30, 2016

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1-About the Company 6

Hemispherx Biopharma Inc-Key Facts 6

Hemispherx Biopharma Inc-Key Employees 7

Hemispherx Biopharma Inc-Key Employee Biographies 8

Hemispherx Biopharma Inc-Major Products and Services 9

Hemispherx Biopharma Inc-History 10

Hemispherx Biopharma Inc-Company Statement 13

Hemispherx Biopharma Inc-Locations And Subsidiaries 14

Head Office 14

Other Locations & Subsidiaries 14

Section 2-Company Analysis 15

Hemispherx Biopharma Inc-Business Description 15

Hemispherx Biopharma Inc-SWOT Analysis 16

SWOT Analysis-Overview 16

Hemispherx Biopharma Inc-Strengths 16

Hemispherx Biopharma Inc-Weaknesses 17

Hemispherx Biopharma Inc-Opportunities 18

Hemispherx Biopharma Inc-Threats 19

Hemispherx Biopharma Inc-Key Competitors 20

Section 3-Company Financial Ratios 21

Financial Ratios-Capital Market Ratios 21

Financial Ratios-Annual Ratios 22

Performance Chart 24

Financial Performance 24

Financial Ratios-Interim Ratios 25

Financial Ratios-Ratio Charts 26

Section 4-Company's Lifesciences Financial Deals and Alliances 27

Hemispherx Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 27

Hemispherx Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 28

Hemispherx Biopharma Inc, Recent Deals Summary 29

Section 5-Company's Recent Developments 30

Mar 31, 2017: Hemispherx Biopharma Announces Financial Results for the Year Ended December 31, 2016 30

Nov 14, 2016: Hemispherx Biopharma Announces Financial Results in its Quarterly Report for the Nine Months Ended September 30, 2016 31

Sep 22, 2016: Hemispherx Biopharma Announces Granting of Final Settlement of Derivative and Class Action Case 32

Aug 19, 2016: Hemispherx Biopharma Forms Scientific Advisory Board to Provide Additional Scientific and Pharmaceutical Expertise 33

Aug 15, 2016: Hemispherx Biopharma Announces Financial Results for the Six Months Ended June 30, 2016 34

Jul 19, 2016: Hemispherx Biopharma Bolsters Manufacturing and Scientific Capabilities Through Key Consulting and Management Appointments 35

Jul 14, 2016: Hemispherx Outlines Key Elements of Strategic Growth Plan and Commitment to Transparency 36

Jun 08, 2016: Hemispherx Biopharma Enters into Settlement Agreements Dismissing All Pending Shareholder Derivative Litigation, Resolving Disputes with Insurance Carriers 37

May 16, 2016: Hemispherx Biopharma Announces Financial Results for the Three Months Ended March 31, 2016 38

Apr 20, 2016: Hemispherx Biopharma Retains Huron Consulting Group to Support Partnering Strategy and Planning for Alferon and Ampligen 39

Section 6-Appendix 40

Methodology 40

Ratio Definitions 40

About GlobalData 44

Contact Us 44

Disclaimer 44

List of Figures

Hemispherx Biopharma Inc, Performance Chart (2012-2016) 24

Hemispherx Biopharma Inc, Ratio Charts 26

Hemispherx Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 27

Hemispherx Biopharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 28

List of Tables

Hemispherx Biopharma Inc, Key Facts 6

Hemispherx Biopharma Inc, Key Employees 7

Hemispherx Biopharma Inc, Key Employee Biographies 8

Hemispherx Biopharma Inc, Major Products and Services 9

Hemispherx Biopharma Inc, History 10

Hemispherx Biopharma Inc, Other Locations 14

Hemispherx Biopharma Inc, Subsidiaries 14

Hemispherx Biopharma Inc, Key Competitors 20

Hemispherx Biopharma Inc, Ratios based on current share price 21

Hemispherx Biopharma Inc, Annual Ratios 22

Hemispherx Biopharma Inc, Annual Ratios (Cont...1) 23

Hemispherx Biopharma Inc, Interim Ratios 25

Hemispherx Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 27

Hemispherx Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 28

Hemispherx Biopharma Inc, Recent Deals Summary 29

Currency Codes 40

Capital Market Ratios 40

Equity Ratios 41

Profitability Ratios 41

Cost Ratios 42

Liquidity Ratios 42

Leverage Ratios 43

Efficiency Ratios 43

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

select a license

Single User License
USD 125 INR 8044
Site License
USD 250 INR 16088
Corporate User License
USD 375 INR 24131

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com